Organization · Venture Capital
Versant Ventures
Versant Ventures is a venture capital firm based in San Diego, California, focusing on biotechnology investments. They leverage scientific advancements to create and support early-stage companies in the life sciences sector.
Overview
What Versant Ventures does
What Versant Ventures is
Versant Ventures is a venture capital firm based in San Diego, California, focusing on biotechnology investments. They leverage scientific advancements to create and support early-stage companies in the life sciences sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1999
- Approximate age
- About 27 years
- Structured capabilities
- Funder
- Last reviewed
- February 28, 2026
Official channels
Find Versant Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Versant Ventures as a funder
Investment thesis
Leading biotech VC with hands-on venture creation and Discovery Engines across seed to growth
Focus narrative
Biotech, healthcare, digital health. Seed through growth equity. Global with US and Europe focus.
Value beyond capital
In-house Discovery Engines for venture creation. Deep biotech operational expertise. Hands-on from inception.
Terms and economics
- Typical check
- $5,000,000–$50,000,000
- Sweet spot
- $15,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Growth Equity
- Regions
- Europe · Global · North America · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 190
- Investments in the last 12 months
- 25
- Last recorded investment
- December 1, 2025
- Recorded notable exits
- Jazz Pharmaceuticals, Insulet, Inari Medical, Genomic Health, and Kythera
Portfolio context
190 companies. 131 exits. Jazz Pharmaceuticals, Insulet, Inari Medical, Genomic Health, Kythera.
Common questions
What to know about Versant Ventures
Upseed classifies Versant Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
February 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.